Please login to the form below

Not currently logged in

Acorda Therapeutics appoints chief medical officer

Interim CMO Dr Burkhard Blank takes on the post in a permanent capacity

New York-based biotech Acorda Therapeutics has appointed Dr Burkhard Blank as its chief medical officer.

Dr Blank has served in the role in a temporary capacity since January this year and now takes on the post permanently.

He brings over 25 years of industry experience to Acorda, and has held senior leadership positions at Altus Pharmaceuticals, Herantis Pharma and Laurantis Pharma.

Prior to this, Dr Blank worked at Boehringer Ingelheim, first as its global head for regulatory affairs before serving as its chief medical officer between 2001 and 2006.

Dr Ron Cohen, president and chief executive of Acorda, said: “I am delighted that Burkhard has joined Acorda as our chief medical officer.

“Burkhard brings to Acorda an impressive record of successful drug development and approved NDAs. This will benefit Acorda's entire pipeline, including our late-stage development programs, CVT-301 and tozadenant for Parkinson's disease.”

5th July 2016

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...